Sunday, April 19, 2015 1:19:58 AM
MultiStem group, N=65 Placebo, N=61
Got both TPA+MR N=10?? N=9
Not both TPA+MR N=55?? N=52
MS <36 H N=27
(and No TPA+MR)
MS >36 H N=28??
DEATH N=4/65 (6.2%) N=9/61 (14.8%)
Excellent N=10/65 (15.4%) N=4/61 (6.6%) p=0.10
Outcome
POST HOC ANALYSIS: NO TPA+MR, MS<36H
N=27 N=52
Excellent N=5/27 (18.5%) N=1/52 (1.9%) p=0.03
Outcome
Above has excluded some folks with excellent outcomes, who also got TPA and MR: N=3-5?/10? N=3/9
(30-50% who got both TPA and MR did excellent, regardless of treatment, and it is this confounding that the post-hoc analysis tried to remove - in addition to the time window effect)
If add them back in, still have significant improvement with MultiStem when given <36 hours after stroke:
Excellent N=~8/32 (25%) N=4/61 (6.6%)
Outcome
If these results hold in a larger trial, in which MS is consistently given earlier (24-36H), then this would be a home run. I'm not even sure they need to wait 24H like they do now. I guess they tried to remove the confounding of stroke patients who spontaneously recover or worsen. Maybe they should open treatment from 12-36H, since earlier treatment clearly was better.
Can you imagine improving the outcomes to excellent for 4x as many people that suffer moderate to severe strokes (NIHSS from 8-20, mean 13 in this study)? Instead of only 5-10% recovering to "normal", you could have 25% being normal, a huge improvement for these folks.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM